ArticleBMC geriatrics2026
Influence of drugs on blood potassium levels in older, multi-medicated patients - results of two cohort studies focusing on adverse drug reactions.
Article in BMC geriatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05247814 (Individual Patient Risk Profiles for Adverse Drug Reactions), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Individual Patient Risk Profiles for Adverse Drug Reactions: Establishing a Consecutive Research Cohort in an Interdisciplinary Polypharmacy Consultation Service of a Geriatric University Outpatient Department
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMany drugs influence blood potassium levels and are often prescribed to older adults. Aim of this study was to estimate the extend of potassium level changes of drugs in the case of older, multi-medicated patients respecting renal function.
methodsData of patients from an outpatient clinic (polypharmacy consultations hours) at the University Hospital RWTH Aachen and from a prospective, multicenter study on adverse drug reactions in emergency departments (ADRED) was used. Data of patients aged ≥ 70 years taking ≥ 3 drugs with available blood potassium levels were included. Quantile regression models were used to analyze drug effects in the context of multi-medication.
resultsIn total, N = 1097 patient cases were included with hypokalemia in 28.4% (n = 311) and hyperkalemia in 20.3% (n = 223). Male sex, use of low-ceiling diuretics, loop diuretics, mineralocorticoid receptor antagonists (MRAs), angiotensin-converting-enzyme inhibitors/ angiotensin II receptor blockers, number of other drugs, and CKD stage were associated with serum potassium levels and included in quantile regression models. In CKD stages 1 and 2, the use of MRAs (+ 0.49, p = 0.002), together with low-ceiling diuretics (-0.54, p < 0.001) had highest impact on serum potassium levels. In CKD stage 3, use of low-ceiling diuretics (-0.52, p < 0.001) and in CKD stages 4 and 5, the use of MRAs (+ 0.86, p < 0.001) had highest impact on serum potassium levels.
conclusionsHypo- as well as hyperkalemia occur frequently in geriatric, multi-medicated patients. While renal function is an important predictor of blood potassium levels, drug effects can differ per drug class in the context of multi-medication.
trial registrationThe ADRED-study is registered at the German Clinical Trials Register under: DRKS00008979. The cohort study of the polypharmacy consultation hours at the University Hospital RWTH Aachen is registered at the ClinicalTrials.gov under: NCT05247814.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.